Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroids in Severe Pneumocystis Pneumonia in Non-HIV Immunocompromised Patients
NCT02944045Phase 3Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2017
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Pneumocystis jirovecii pneumonia (PJP) comparing Placebo with Steroids (2 arms). Primary endpoint: Mortality at 28 days. Status: unknown.
02
Drugs
methylprednisolone
03
Conditions
Pneumocystis jirovecii pneumonia (PJP)
Beyond the preview
Go deeper on NCT02944045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02944045.